Skip to content

Clinical trials

Phase 2 Lymphoma, T-Cell, Cutaneous trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Cutaneous Phase: Phase 2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20052
20072
20161
20181
20192
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Fred Hutchinson Cancer Center3
4SC AG1
BeiGene1
BioCryst Pharmaceuticals1
Innate Pharma1
Kyowa Kirin, Inc.1
Novartis Pharmaceuticals1
Prescient Therapeutics, Ltd.1
miRagen Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Cutaneous14
Mycosis Fungoides11
Sezary Syndrome9
Lymphoma, Non-Hodgkin6
Recurrence6
Immunoblastic Lymphadenopathy5
Lymphoma, Large-Cell, Anaplastic5
Burkitt Lymphoma4
Hodgkin Disease4
Leukemia, Hairy Cell4

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.